{"created":"2024-11-29T04:54:04.276594+00:00","id":2001699,"links":{},"metadata":{"_buckets":{"deposit":"6bf5b78d-5f60-4d66-a6d5-6d0a7a07a1e4"},"_deposit":{"created_by":8,"id":"2001699","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2001699"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02001699","sets":["1732778801467:1732778962699:1732855259895"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Takeda, Isao","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Iwadate, Haruyo","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Sugisaki, Kota","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takahashi, Atsushi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nogae, Syoji","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kanno, Takashi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kasukawa, Reiji","creatorNameLang":"en"}]}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2005 The Fukushima Society of Medical Science","subitem_rights_language":"en"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"anti-DNA antibody","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"anti-ribosomal P antibody","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"lymphocytopenia","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"vascular thrombosis","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Antibodies, Antinuclear","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Antiphospholipid Syndrome","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Autoantibodies","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Glycoproteins","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Humans","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Lupus Erythematosus, Systemic","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Lupus Nephritis","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Lymphopenia","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Ribosomal Proteins","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Thrombosis","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"beta 2-Glycoprotein I","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"In the present study, anti-ribosomal P antibody in sera of patients with systemic lupus erythematosus was assayed using an enzyme-linked immunosorbent assay, and its association with clinical symptoms of the patients was analyzed. The presence of anti-ribosomal P antibody was associated with increased frequency of lupus nephritis in the presence of anti-DNA antibody, and was associated with increased frequency of vascular thrombosis in the presence of anti-beta2 glycoprotein I antibody and/or lupus anticoagulant. The level of anti-ribosomal P antibody correlated inversely with the peripheral lymphocyte counts.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"The Fukushima Society of Medical Science","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"0016-2590","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2185-4610","subitem_source_identifier_type":"EISSN"},{"subitem_source_identifier":"AA0065246X","subitem_source_identifier_type":"NCID"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2005-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"18","bibliographicPageStart":"11","bibliographicVolumeNumber":"51","bibliographic_titles":[{"bibliographic_title":"Fukushima Journal of Medical Science","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5387/fms.51.11","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"16167669","subitem_relation_type_select":"PMID"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"2006278046","subitem_relation_type_select":"ICHUSHI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2011-05-26"}],"displaytype":"detail","filename":"FksmJMedSci_51_p11.pdf","filesize":[{"value":"534.2 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://fmu.repo.nii.ac.jp/record/2001699/files/FksmJMedSci_51_p11.pdf"},"version_id":"c053409c-b6dc-4e19-835d-a56275d8f33b"}]},"item_title":"Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus","item_type_id":"40002","owner":"8","path":["1732855259895"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2011-05-26"},"publish_date":"2011-05-26","publish_status":"0","recid":"2001699","relation_version_is_last":true,"title":["Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2024-12-11T09:20:09.551613+00:00"}